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Abstract. Deoxyuridine suppression tests have been performed by
two different methods on six normoblastic and eight megaloblastic
marrows. A good correlation was obtained between the results by the
modified and the original methods. The simplified method was found
to be applicable for a clinical purpose to diagnose megaloblastosis in
the marrow. Uptake of 3H-deoxyuridine into DNA and effect of vari-
ous concentrations of thymidine was studied on five normoblastic and
six megaloblastic marrows. In megaloblastic marrows, a greater
amount of thymidine was required to obtain the same rate of suppres-
sion of 3H-deoxyuridine incorporation into DNA than in normoblastic
marrows. Impairment of thymidine incorporation into DNA in mega-
loblastic marrows was not revealed. Therefore, lower rate of suppres-
sion of 3H-deoxyuridine by thymidine in megaloblastic marrows may
be due to impairment of the incorporation of deoxyuridine before the
addition of thymidine.
Deoxyuridine suppression (DUS) test has been proved to be of great value as
a diagnostic tool of megaloblastic bone marrow. The interrelated biochemical
pathways are shown in Fig. I. Killman (I) introduced this test first using auto-
radiographic techniques. Metz et at. (2) modified the method for extraction of
DNA. Several modifications have been proposed since then (3-6). Each of these
modified methods is still too far complicated from clinical use. We have tried to
modify the method as simply as possible and compared the result obtained by the
new method with the method of Metz et at. (2). We also studied the effect of
preincubation of marrow cells with cold thymidine (TdR) on the incorporation of
3H-deoxyuridine (UdR) to elucidate a biochemical basis of this test.
* British Council scholar.
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Fig. 1. Synthetic pathway of thymine l1loiety of DNA from deoxyuridine. THF=tetra-
hydrofolic acid, UdR=deoxyuridine, TdR=thymidine, dUMP=deoxyuridine monophos-
phate, dTMP =.~deoxythymidinemonophosphate, dTTP =deoxythymidine triphosphate, Met =c
methionine, Homo=homocysteine, Ser=serine, Gly=glycine. Vitamin B12 is required when
THF is formed from 5-methyl THF coupled with methionine synthesis.
MATERIALS AND METHODS
Bone marrow (3-5 ml) aspirated from the sternal bone or the anterior iliac
crest was immediately mixed in a universal tube containing 10 ml of cold
Hanks' balanced salt solution (HBSS) (pH 7.4) with 100 units/ml preservative
free heparin. At the same time, venous blood was taken for the autologous
serum. The samples were forced through a 25-gauge needle twice to break
down cell clumps. The cells were washed twice with 10 ml of cold HBSS and
then suspended in a mixture consisting of one part of autologous serum and 2
parts of HBSS. Cell counts were adjusted to 6,000-24,000 nucleated cells/mm3.
The volume of serum-HBSS solution added was usually about two times volume
of washed bone marrow cells. DDS test was performed on half of this cell sus-
pension by the method described by Metz et al. (2). Another half of the cell
suspension was used for the modified method as follows. To 0.5 ml of the mar-
row cell suspension was added 0.4 ml of HBSS (Control) or 0.3 ml of HBSS with
0.1 ml of 2'-deoxyuridine (1 p mole/ml) (Test). Both Control and Test tubes were
set up in triplicate. The tubes were incubated for 1 hr at 37°C by shaking these
tubes gently (90 cycle/min) on a metabolic shaker. After the incubation, 0.1 ml
of 3H_TdR solution (5 pCi/ml, specific activity: 23-25.6 Ci/mmole) was added
to each tube. The tubes were incubated further at 37°C for 3 hr, then washed
three times in cold 0.9% NaCl solution. After mixing well, two 0.1 ml aliquots
of each cell suspension were delivered to each Whatman filter discs (1.9 cm in
diameter and 3 mm in grade). The discs were dried overnight, immersed in a
large volume (200 ml) of ice cold 10% trichloroacetic acid for 20 min at 4°C.
The discs were placed into two changes of 100 ml volume of absolute methanol
for 10 min each. After a brief rinse in acetone, the discs were dried and added
with liquid scintillator solution (10 ml of toluene containing 0.3% 2,5-diphenyl-
oxazole and 0.03% p-bis (2-1, 5 phenyloxazolylbenzene)). The radioactivi ties on
the discs were determined using a liquid scintillation counter (LKB-Wallac).
Quenching was corrected by the external standard method. Results were ex-
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pressed as a percentage of the counts on the discs from the tubes incubated with
UdR (Test) to those without UdR (Control).
Incorporation of 3H-UdR into DNA and effect of preincubation of the bone
marrow cells with TdR (10-LlO-5 pmole) were examined using the method of
Metz et ai. (2). Marrow cell suspension (0.3 ml) was added with 0.1 ml of TdR
solution (1-1O-4pmole/ml in HBSS) and 0.5 ml of HBSS. Triplicate tubes were
incubated for I hr at 37°C. As a control, triplicate tubes containing 0.3 ml of
marrow cell suspension and 0.6 ml of HBSS were also incubated. After incuba-
tion,O.1 ml of 3H-UdR (10 /lCi/ml, specific activity: 21-27 Ci/mmole) was added
to each tube. After further incubation for 3 hr, cells were washed and DNA
was extracted as described by Metz et ai. (2). Suppression of the incorporation
of 3H-UdR by TdR was expressed as the percentage of the counts of the tubes
with TdR to those without TdR. DUS test was performed on the same mar-
rows at the same time. Absolute values of the 3H-TdR and 3H-UdR which were
incorporated into DNA were calculated after converting radioactivity into dis-
integration per minute (dpm) by the use of the external standard method. Dpm
of the standard 3H_TdR and 3H-UdR solutions (0.01 ml) were also counted. Ab-
solute amount of 3H-TdR and 3H-UdR was expressed as pmoles/pg DNA and
pmoles/106 nucleated cells.
RESULTS
Two DUS methods were compared on six normoblastic and eight megalo-
blastic marrows. A good correlation was observed between results by the modi-
fied method and that of Metz et ai. (2) (Table 1). In this method, all normoblastic
marrows showed DUS value below 10% (range: 0.2-10%). In contrast, the
levels in megaloblastic marrows were more than 10% (range: 13.7-66.5%). As
many reports concluded, DUS level below 10% should be regarded as normal
value.
Effects of various concentrations of TdR on the incorporation of 3H-UdR
were shown in Fig. 2. Inhibition of the incorporation of 3H-UdR was observed
as TdR concentration increased. A significant difference of the inhibitory effect
of TdR was observed between normoblastic and megaloblastic marrows by add-
ing 10-3 and 10-4 pmole of TdR. In normoblastic marrows, TdR suppressed the
incorporation of 3H-UdR to a larger extent than in megaloblastic marrows. Ab-
solute amount of 3H-TdR and 3H-UdR incorporated into DNA and effect of each
UdR and TdR were shown in Tables 2 and 3. In normoblastic marrows (five
cases), 3H-TdR uptake was suppressed by the addition of UdR (0.1 ,umole) from
29.5 X 10-8 pmole/pg DNA and 37.1 X 10-7 pmole/10 6 cells to 1.8 and 2.5, re-
spectively. In megaloblastic marrows (six cases), suppression by UdR was from
26.2x 10-8 pmole/pg DNA and 22.6 X 10-7 pmole/l0 6 cells to 8.3 and 10.1, re-
spectively. Effects of 10-3 ,umole of TdR on the incorporation of 3H-UdR were
as follows: in normoblastic marrows, from initial amounts of 12.8 X 10-8
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TABLE 1. HEMATOLOGICAL DATA AND RESULTS OF DEOXYURIDINE SUPPRESSION (DUS) TESTS
Case Hb MCV Serum Red cell Serum DUSby DUSby
no.
Diagnosis Bone marrow (g/d1) (fl) folate folate V.BI2 Metz et al. modified(f1g/1) (pg/1) (ng/1) (%) method (%)
Iron deficiency Normoblastic 3.8 600 145 8.8 10.0
2 ITP 9.1 90 13.2 375 135 2.7 0.2 ~
" >-1
3 Pregnancy 11. 3 97 20 627 210 2.8 4.0 :>-
"
p
c::
0
4 Coronary heart disease
"
15.8 82 5.5 6.0 F
5 Pregnancy
"
8.8 96 738 718 3.0 1.5 ~
~
6 Liver cirrhosis
"
11. 0 115 1.4 134 525 4.8 4.4 IJ1
>-1
7 Pernicious anemia Megaloblastic 10. 7 87 7.4 65 16.5 13.7 :>-"l
"l
0
8 Folate deficiency 8.6 85 0.4 78 120 51. 0 43.6 :>;1
"
0
9 Vegetarian, V. BIZ def. 11.5 104 2.4
to>
"
90 29.0 29.7
"'0-
10 Pernicious anemia 13. 1 114 12.8 134 51. 7 49.6 t-<
" 0
11 12.9 98 9. 2 38 47.7 53.6 ::t:
" "
:>-
z
12
:>-
" "
7.3 97 50.6 66.5 :>;1Z
13 Folic acid deficiency
"
11.5 97 2.3 102 100 42.4 52.3
14 Pernicious anemia
"
10.2 117 13.7 199 38 32.9 39.3
-------- -~~-
Normal values 12.5-17 80-92 2-15 145-450 170-1000 <10 <10
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TABLE 2. UPTAKE OF 3H-TdR AND 3H-UdR IN NORMOBLASTIC MARROW CELLS AND EFFECTS OF PREINCUBATION
WITH UdR (10-1 ,umo1e) AND TdR (10-3 ,umole) RESPECTIVELY
DUS
---------------
Case test 3H-TdR uptake per DNA 3H-TdR uptake per cell 3H-UdR uptake per DNA 3H-UdR uptake per cellno. (%) (X 10-8 flmo1e/ J!g DNA) (x 1O-7,umo1e/106 cells) (X 10-8 ,umo1e/flg DNA) ( X 10-7 ,umo1e/106 ce lIs)
---------~.
15 3.8 38.8-1. 5 68.3-3.2 (4.7%) 9.2-1. 6 (18. 0%) 24.4-2.4 ( 9.9%)
16 8.3 14.5-1.2 20.0-1. 2 (6.2%) 4.4-1.0 (22.4%) 12.5-2.5 (19.6%)
17 7.0 21.0-1.5 24. 7-2.4 (9. 7%) 14.3-1.9 (13.0%) 24.9-3.4 (13.5%)
18 9.2 33.6-3.1 34.0-2.8 (8.1%) 20.8-5.8 (27.8%) 21. 0-5.1 (24.3%)
19 4.1 39.4-1. 6 38. 7-2. 7 (6.9%) 15.2-1.8 (11.8%) 17.3-1. 8 (10. 2%)
------~--
Mean 6.5 29.5-1. 8 37.1-2.5(7.1%) 12.8-2.4(18.6%) 20.0-3.0 (15.5%)
S.E. 1. 09 5.0 0.3 8.50.3 2.80.9 2.3 0.6
Left part of each column shows the absolute amount of 3H-TdR or 3H-UdR without addition of UdR or TdR respectively. Right
part of each column shows the amount after addition of UdR or TdR respectively. In brackets, percentage of the amount of 3H-
TdR or 3H-UdR after addition of UdR or TdR respectively. S. E. =Standard error of the mean.
TABLE 3. UPTAKE OF 3H-TdR AND 3H-UdR IN MEGALOBLASTIC MARROW CELLS AND EFFECTS OF PREINCUBATION
WITH UdR (10-1 ,umole) AND TdR (1O-3 ,umo1e) RESPECTIVELY
Case LJUoJ 3H-TdR uptake per DNA 3H_TdR uptake per cell 3H-UdR uptake per DNA 3H-UdR uptake per cell
no.
test (x 10-8 J!mole/,ug DNA) (x 10-7 ,umole/106 cells) (X 10-8 ,umo1e/,ug DNA) (x 10-7 ,umo1e/106 cells)(%)
----
20 56.2 5.3- 3.0 8.5- 3.7 (43.3%) 2.3-1.1 (45.7%) 4.4-1. 4 (31. 8%)
21 63. 7 23.4-14.9 5.63.0(55.0%) 5.7-3.5 (61. 8%) 0.8-0.5(70.5%)
22 15. 7 16.3- 2.6 1. 6- O. 2 (15. 9%) 4.5-0.9 (19.4%) 1. 5-0. 3 (17.4%)
23 22.4 63.9-14.3 47.8-10.6 (22.2%) 6.4-2.4 (36.8%) 3.3-0.5 (16.6%)
24 38.0 29.1- 6.3 17.9- 6.9 (38.8%) 6.5-3.5 (53.9%) 6.5-2.3 (35.4%)
25 44.4 19.3- 8.6 54.6-36.0 (65.9%) 3.5-2.4(67.9%) 17. 3-9. 4 (54. 3%)
Mean 40. 1 26.2- 8.3 22.6-10.1 (44.5%) 4.8-2.4 (48.6%) 5.6-2.4 (42.8%)
S.E. 7.6 8.2 2.2 9.3 5.4 0.70.5 2.5 1. 4
- --_.--._.-----
p* p<O.OOl N. S. p<O.Ol N.S. N.S. p<O.Ol N.S. p<O.Ol N.S.
* Significance of the means of the Table 3 are evaluated against the means in the Table 2. N. S. =not significant
t::l
o
o
:><
....-::
c
'"1
0:
~.
[fJ
C
"0
"0
'"1
.0
VJ
VJ
'0'
~
""'3
o
~
......
......
-...J
5
Taguchi et al.: Deoxyuridine suppression test: a comparison of two methods and
Produced by The Berkeley Electronic Press, 1977
118 H. T AGUCHI, D. M. STAFFORD and 1. CHANARIN
«z_
Cl -o
o ....CC
.- 0
C U
o Q.l
._~
1i5 .....
.... 0
0 .....
c-Q.l
.... =
o <1JU .....
C C
.- Q.l
o:::U
"0 ....7;
~
100%
80%
60%
40%
20%
*
~\
\
\
\
\
\~
\
\
\
I
\
\
I
\
\
\
\
\
\
\
\~
"
"
...·0.._..
pmole/fig DNA and 20.0 X 10-7 pmole/IO G cells to 2.4 and 3.0, respectively. In
megaloblastic marrows, from 4.8 X 10-8 pmole/pg DNA and 5.6 X 10-7 pmole
/10 6 cells to 2.4 and 2.4, respectively.
Although no difference of the initial 3H-TdR incorporation was observed
between normoblastic and megaloblastic marrows, 3H-TdR uptake was signif-
icantly higher in megaloblastic marrows than in normoblastic ones after adding
UdR. On the other hand, initial uptake of 3H-UdR was significantly reduced
in megaloblastic marrows, although 3H-UdR uptake after an addition of TdR
was the same level in both megaloblastic and normoblastic marrows.
DISCUSSION
The DUS test has been appreciated to be of great value for making the diag-
nosis of megaloblastic anemia (2, 6, 7). Although several modifications of the
original Killman's method appeared (2, 3, 5, 6), no attempt has been made to
compare the results obtained from different methods on the same patients. We
modified slightly the method described by Wickramasinghe and Longland (6).
They counted cell numbers of each tube after incubation. We counted cell num-
bers before delivering cells into tubes, and after that, the same volume of cell
suspension was carefully pipetted into six tubes (three each for Control and UdR-
added Test). A good correlation with that of Metz et at. (2) was obtained by the
6
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modified method. Therefore, this simple method can be applied for a diagnostic
tool of megaloblastic anemia. Normal range was 0.2-10%. All megaloblastic
marrows showed values over 10%. Although we had one case of megaloblastic
anemia showing 13.7% in DUS test, the bone marrow of the case was megalo-
blastic in very mild degree. Sive, Green and Metz (4) reported that nine normal
marrows showed the levels ranging 2.8-11.9% by this test. The diagnosis of
megaloblastic anemia should be avoided if the DUS test value falls between 10%
and 15%. In the marrows of patients receiving anticonvulsants, discrepancies
were reported between the DUS test and macrocytosis or megaloblastosis (8).
According to the observations of Taguchi et al. (9), in four normoblastic marrows
from the patients receiving anticonvulsants, DUS levels were between 10-15%.
Another occasion in which DUS test is not reliable is the association of iron de-
ficiency (10, 11). Patients may have a vitamin B12 or folate deficiency even if
DUS test is below 15%, if iron deficiency is associated. Therefore, on those occa-
sions, we should use another test or should repeat DUS test after iron therapy.
Killman (1) explained the abnormality of DUS test in megaloblastic marrow
by a block of methylation of deoxyuridylate. On the other hand, Beck (12) pro-
posed that UdR inhibited DNA synthesis in vitro and that in megaloblastic mar-
row cells, UdR could not suppress the incorporation of 3H-TdR to the same
extent as in normoblastic marrows because the uptake of 3H-TdR without UdR
was already low to begin with. However we could not confirm his result. Ab-
solute amount of TdR incorporated into DNA was not reduced in megaloblastic
marrows before the addition of UdR. Suppression of 3H-TdR incorporation by
UdR was actually less in megaloblastic marrows than in normoblastic ones.
Although Wickramasinghe and Longland (11) reported that 3H-TdR uptake per
103 DNA synthesizing cells was approximately half the mean value of the nor-
mal marrows, the calculation of DUS test is not based on the DNA synthesizing
cells but on total cells or total DNA amount of the marrow cells. Therefore, it
seems to be reasonable to conclude that addition ofUdR reduces the incorporation
of 3H-TdR to a greater extent in normoblatic marrows than in megaloblastic
ones.
In a reciprocal experiment, 3H-UdR incorporation into DNA was lower in
megaloblastic than in normoblastic marrows. This result can be easily explained
by the present knowledge that the pathway from deoxyuridylate to thymidylate
is inhibited in megaloblastic anemia. It is rather difficult to explain the fact that
larger amount of TdR was necessary to suppress 3H-UdR incorporation in mega-
loblastic than in normoblastic marrows. As mentioned previously, TdR uptake
was not reduced in megaloblastic marrows. Although percentage suppression of
3H-UdR uptake was lower in megaloblastic marrows, no difference was seen in
absolute amount of 3H-UdR uptake after preincubation with TdR. Therefore,
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lower rate of suppression of 3H-UdR by TdR in megaloblastic marrows may be
due to low 3H-UdR uptake before the addition of TdR, and calculated percentage
in megaloblastic marrows showed higher levels than in normoblastic marrows.
REFERENCES
1. Killman, S-A.: Effect of deoxyuridine on incorporation of tritiated thymidine: difference
between normoblasts and megaloblasts. Acta Med. Scand. 175, 483-488, 1964.
2. Metz, j., Kelly, A., Sweet, V. C., Waxman, S. and Herbert, V.: Deranged DNA synthesis
by bone marrow from vitamin B12 deficient humans. Br.]. Haematol. 14, 575-592, 1968.
3. Tisman, G., Herbert, V., Go, L. T. and Brenner, L.: Inhibition by penicillamine of DNA
and protein synthesis by human bone marrow. Proc. Soc. Exp. BiD!. Med. 139, 355-363,
1972.
4. Sive, J., Green, R. and Metz, J.: Effect of trimethoprim on folate-dependent DNA syn-
thesis in human bone marrow. ]. Clin. Pathol. (Lond) 25, 194-197, 1972.
5. Herbert, V., Tisman, G., Go, L. T. and Brenner, L.: The dU suppression test using 1251_
UdR to define biochemical megaloblastosis. Br. j. Haematol. 24, 713-723, 1973.
6. Wickramasinghe, S. N. and Longland, J. E.: Assessment of deoxyuridine suppression test
in diagnosis of vitamin B12 or folate deficiency. Br. Med.]. 3, 148-150, 1974.
7. Wickramasinghe, S. N. and Saunders, J.: Correlations between the deoxyuridine-sup-
pressed value and some conventional haematological parameters in patients with folate
or vitamin Bl2 deficiency. Scand.]. Haematol. 16, 121-127, 1976.
8. Wickramasinghe, S. N., Williams, G., Saunders, J. and Durston, J. H. J.: Megaloblastic
erythropoiesis and macrocytosis in patients on anticonvulsants. Br. Med.]. 4, 136-137,
1975.
9. Taguchi, H., Laundy, M., Reid, C., Reynolds, E. H. and Chanarin, 1.: The effect of
anticonvulsant drugs on thymidine incorporation and deoxyribonucleic acid synthesis by
human bone marrow cells. Br.]. Haematol. in press.
10. Van Der Weyden, M., Rother, M. and Firkin, B.: Megaloblastic maturation masked by
iron deficiency: a biochemical basis. Br.]. Haematol. 22, 299-307, 1972.
11. Wickramasinghe, S. N. and Longland, j. E.: Rate of incorporation of tritiated thymidine
into DNA of normoblastic and megaloblastic bone marrow cells in vitro. Acta Haematol.
52, 14-23. 1974.
12. Beck, W. S.: Validity of conclusions based on the "Killman Experiment". In Cobalamin-
Biochemistry and Pathophysiology, ed. B. M. Babior, Wiley, New York, pp. 430-433, 1974.
8
Acta Medica Okayama, Vol. 31 [1977], Iss. 2, Art. 3
http://escholarship.lib.okayama-u.ac.jp/amo/vol31/iss2/3
